Name : C17orf66 Antibody
Supplier : BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price :263
SKU : GEN9197474951
| Long name | C17orf66 Primary Polyclonal Antibody |
| Also known as | C17orf66 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | C17orf66 |
| Specificity | This is a highly specific antibody against C17orf66 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human C17orf66 |
| Gene ID number | 256957 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | Alexander disease, BRCA1 is directly involved in DNA repair, Birt-Hogg-Dube syndrome and Canavan disease are also associated with chromosome 17, Chromosome 17 is also linked to neurofibromatosis, Chromosome 17 makes up over 2, Like p53, Malfunction or loss of p53 expression is associated with malignant cell growth and Li-Fraumeni syndrome, Tumor suppressor p53 is necessary for maintenance of cellular genetic integrity by moderating cell fate through DNA repair versus cell death, Two key tumor suppressor genes are associated with chromosome 17, a condition characterized by neural and epidermal lesions, and dysregulated Schwann cell growth, colon, namely, p53 and BRCA1, prostate gland and fallopian tubes, specifically it is recognized as a genetic determinant of early onset breast cancer and predisposition to cancers of the ovary, 200 genes, 5% of the human genome with about 81 million bases encoding over 1, C17orf66 is a 570 amino acid protein that is encoded by a gene mapping to human chromosome 17 |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | FLJ32830, Uncharacterized protein C17orf66, hypothetical protein LOC256957, chromosome 17 open reading frame 66 |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | C17orf66 |
| Short name | C17orf66 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | C17orf66 (Antibody to) |
| Alternative technique | antibodies |
| Identity | 26548 |
| Gene | HEATR9 |
| Long gene name | HEAT repeat containing 9 |
| Synonyms gene | C17orf66 |
| Synonyms gene name | chromosome 17 open reading frame 66 |
| Synonyms | FLJ32830 |
| Locus | 17q12 |
| Discovery year | 2005-12-16 |
| GenBank acession | AK057392 |
| Entrez gene record | 256957 |
| Pubmed identfication | 12477932 |
| RefSeq identity | NM_152781 |
| Havana BLAST/BLAT | OTTHUMG00000188393 |